Treatment options in massive pulmonary embolism during pregnancy; A case-report and review of literature
- 31 May 2009
- journal article
- case report
- Published by Elsevier BV in Thrombosis Research
- Vol. 124 (1), 1-5
- https://doi.org/10.1016/j.thromres.2009.03.001
Abstract
Systemic thrombolysis with recombinant tissue plasminogen activator (rt-PA), streptokinase or urokinase is considered as high-risk treatment in pregnancy. However, several reports have described the successful use of systemic thrombolysis in pregnant patients with massive pulmonary embolism and haemodynamic instability. Case: We describe a 34-year old, pregnant female, who presented at 25 weeks of gestation with an acute collapse with reduced consciousness and shortness of breath caused by massive pulmonary embolism. Because of significant haemodynamic instability, increased right ventricular pressure and no improvement after intravenous heparin, thrombolytic therapy was administered. The response to thrombolytic therapy was excellent. No severe haemorrhagic complications were observed. Anticoagulant therapy with LMWH was continued until delivery. A healthy child was born at term. Review: In English literature, 13 patients received thrombolysis during pregnancy because of pulmonary embolism. No maternal deaths, four non-fatal maternal major bleeding complications, 30.8%;95%CI(9.1-61.4), two fetal deaths, 15.4%;95%CI(1.9-45.5), and five preterm deliveries, 38.5%;95%CI(13.9-68.4), were observed. Surgical embolectomy and catheter embolectomy or catheter thrombolysis has only been performed in 12 patients. Conclusion: The number of reports on thrombolytic therapy, surgical embolectomy and catheter embolectomy or thrombolysis for massive pulmonary embolism during pregnancy are limited. We suggest an international registry for pregnant patients undergoing thrombolysis or embolectomy to gain more information about these treatment options. Nevertheless, complication rates of thrombolytic therapy are acceptable in the light of the underlying disease, and in the meantime, current data do not justify withholding pregnant women from thrombolytic therapy in case of life-threatening PE.Keywords
This publication has 38 references indexed in Scilit:
- Emergency Pulmonary Embolectomy During the Second Trimester of Pregnancy: Report of a CaseSurgery Today, 2007
- Efficacy of thrombolytic agents in the treatment of pulmonary embolismEuropean Respiratory Journal, 2005
- Massive Pulmonary Embolism in Pregnancy Treated With Tissue Plasminogen ActivatorObstetrics & Gynecology, 2005
- Massive Pulmonary Embolism in Pregnancy Treated With Catheter Fragmentation and Local ThrombolysisObstetrics & Gynecology, 2005
- Intrapulmonary artery infusion of urokinase for treatment of massive pulmonary embolism: A review of 26 patients with and without contraindications to systemic thrombolytic therapyClinical Cardiology, 1999
- Catheter-directed thrombolysis for thromboembolic disease during pregnancy: a viable optionThe Journal of Maternal-Fetal Medicine, 1999
- Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?Archives of Internal Medicine, 1997
- Use of Thrombolytics for the Treatment of Thromboembolic Disease During PregnancyObstetrical & Gynecological Survey, 1995
- Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labourIntensive Care Medicine, 1990
- Treatment of Acute Massive Pulmonary Embolism by Streptokinase during Labour and DeliveryBMJ, 1972